Helixbind, Inc.
Biotechnology company · Marlborough, Massachusetts, United States
Helixbind, Inc. is a biotechnology company headquartered in Marlborough, Massachusetts, United States. Its earliest recorded incorporation is in 2012. It has received 20 US government small-business research awards (SBIR/STTR) from health agencies, $43 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $2.9 million sold in a notice filed in 2017.
Helixbind at a glance
What does Helixbind do?
US government research funding
20 SBIR/STTR small-business research awards from US health agencies, $43 million in total (2013 to 2024). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.9 million sold (2017).
Frequently asked questions about Helixbind
Where is Helixbind headquartered?
Helixbind, Inc. is headquartered in Marlborough, Massachusetts, United States.
What does Helixbind do?
Helixbind, Inc. is a biotechnology company.
When was Helixbind founded?
The earliest incorporation on record for Helixbind, Inc. is in 2012, according to public company registers.
Similar companies
- CardioFocus, Inc.Marlborough, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.